CD274 and neoplasm: Previous studies on PD-L1 expression in ILC tumor cells have been limited, but one study reported a PD-L1 positivity rate of 17% in ILC tumor cells using B7-H1 and SP142 antibodies, with a positive cut-off value of more than 5% [52].